Lawmakers have introduced legislation, including S. 3267, to require Medicare coverage for FDA-approved blood-based dementia screenings. The proposed policy aims to facilitate early Alzheimer's detection for seniors starting January 1, 2028.
Analysis generated by AI. Always verify with official sources.